REFERENCE
Sizemore EN, Rivas KM, Valdes J, Caballero J.Enteral vancomycin and probiotic use for methicillin-resistant Staphylococcus aureus antibiotic-associated diarrhoea. BMJ Case Reports: [5 pages], 30 Jul 2012. Available from: URL: http://dx.doi.org/10.1136/bcr-2012-006366 - USA
Additional information
Key words
Methicillin-resistant-Staphylococcus-aureus-infections; adverse reactions; Elderly; Piperacillin/tazobactam; drug-induced; Diarrhoea; Amoxicillin/clavulanic-acid; Nitrofurantoin
An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage
Rights and permissions
About this article
Cite this article
Amoxicillin/clavulanic acid/nitrofurantoin/piperacillin/tazobactam. React. Wkly. 1426, 9 (2012). https://doi.org/10.2165/00128415-201214260-00031
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201214260-00031